PODD
INSULET CORP
CUSIP: 45784P101
INSULET CORP (PODD) — institutional ownership and SEC 13F holdings data. Healthcare sector. Source: SEC EDGAR 13F filings.
About
Insulet Corporation specializes in the development, manufacturing, and sale of innovative insulin delivery systems for patients with diabetes. The company’s flagship product, the Omnipod System, is a tubeless, wearable insulin pump that provides continuous subcutaneous insulin infusion therapy. As a leader in the diabetic technology market, Insulet focuses on improving patient convenience and management through its discreet, automated patch-pump solutions.
Institutional Holders
Source: SEC EDGAR 13F-HR filings from institutional investment managers.
AI Agent
Try asking...